JAMES N. WILSON

Corporate Board Profile

Tech Score: 0/100

← Back to All Directors

CORCEPT THERAPEUTICS INC

Filing Date Source Excerpt
2012-05-21 Mr. Wilson has been Chairman of the Board of NuGEN Technologies, Inc., a provider of systems for genomic analysis, and held executive roles in biotechnology companies, but no programming or technical software skills are indicated.
2013-04-17 Mr. Wilson has been the Chairman of the Board of NuGEN Technologies, Inc., a provider of systems for genomic analysis. From 1991 to 1994, he was Chief Operating Officer of Syntex Corporation... Mr. Wilson received his B.A. and M.B.A. from the University of Arizona.
2014-04-07 Mr. Wilson has been Chairman of the Board of NuGEN Technologies, Inc., a provider of systems for genomic analysis. He has extensive experience in biotechnology but no mention of programming or technical degrees.
2015-04-20 Mr. Wilson received his B.A. and M.B.A. from the University of Arizona. Our Board selected Mr. Wilson to serve as a director because he brings to our Board extensive experience in the biotechnology industry, evidenced by nearly 30 years of representing biotechnology companies as a director or officer.
2016-04-22 Mr. Wilson has been the Chairman of the Board of NuGEN Technologies, Inc., a provider of systems for genomic analysis, and held executive roles in biotechnology companies. He received his B.A. and M.B.A. from the University of Arizona.
2017-04-21 James N. Wilson has served as a director and as Chairman of our Board since 1999. Since 2005, he has also been the Chairman of the Board of NuGEN Technologies, Inc., a provider of systems for genomic analysis. From 2002 to 2009, Mr. Wilson served as the lead independent director of Amylin Pharmaceuticals, Inc., a publicly-traded biopharmaceutical company, and from 1996 to 2001, he was Chairman of the Board of Amira Medical, Inc., which was acquired by Hoffmann-La Roche A.G. From 1991 to 1994, Mr. Wilson was Chief Operating Officer of Syntex Corporation, which was acquired by Roche Holding, Ltd. From 1989 to 1990, Mr. Wilson was Chairman and Chief Executive Officer of Neurex Corporation, which was acquired by Elan Corporation plc. From 1982 to 1988, he was Chief Executive Officer of LifeScan, Inc., which was acquired by Johnson & Johnson Company. Mr. Wilson received his B.A. and M.B.A. from the University of Arizona.
2018-04-24 James N. Wilson has served as a director and as Chairman of our Board since 1999. Since 2005, he has also been the Chairman of the Board of NuGEN Technologies, Inc., a provider of systems for genomic analysis. From 2002 to 2009, Mr. Wilson served as the lead independent director of Amylin Pharmaceuticals, Inc., a publicly-traded biopharmaceutical company, and from 1996 to 2001, he was Chairman of the Board of Amira Medical, Inc., which was acquired by Hoffmann-La Roche A.G. From 1991 to 1994, Mr. Wilson was Chief Operating Officer of Syntex Corporation, which was acquired by Roche Holding, Ltd. From 1989 to 1990, Mr. Wilson was Chairman and Chief Executive Officer of Neurex Corporation, which was acquired by Elan Corporation plc. From 1982 to 1988, he was Chief Executive Officer of LifeScan, Inc., which was acquired by Johnson & Johnson Company. Mr. Wilson received his B.A. and M.B.A. from the University of Arizona.
2019-04-24 James N. Wilson has served as a director and as Chairman of our Board since 1999. From 2005 to 2018, he was also a member of the Board of NuGEN Technologies, Inc., a provider of systems for genomic analysis. He has extensive experience in biotechnology industry as a senior executive and director.
2020-04-27 Mr. Wilson received his B.A. and M.B.A. from the University of Arizona. Mr. Wilson brings to our Board experience in the biotechnology industry, as both a senior executive and director.
2021-04-22 Mr. Wilson brings to our Board experience in the biotechnology industry, as both a senior executive and director.
2022-04-25 Mr. Wilson brings to our Board experience in the biotechnology industry, as both a senior executive and director.
2023-04-14 Mr. Wilson received his B.A. and M.B.A. from the University of Arizona. Mr. Wilson brings to our Board experience in the biotechnology industry, as both a senior executive and director.
2024-04-10 Mr. Wilson received his B.A. and M.B.A. from the University of Arizona. Mr. Wilson brings to our Board experience in the biotechnology industry, as both a senior executive and director.

Data sourced from SEC filings. Last updated: 2026-02-03